Filing Details
- Accession Number:
- 0001209191-21-028191
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-23 19:43:05
- Reporting Period:
- 2021-04-21
- Accepted Time:
- 2021-04-23 19:43:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1528287 | Neuropace Inc | NPCE | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1297260 | M Frank Fischer | C/O Neuropace, Inc. 455 N. Bernardo Avenue Mountain View CA 94065 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-04-21 | 50,000 | $17.00 | 93,291 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2021-04-21 | 21,698 | $0.00 | 21,698 | $17.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
21,698 | 2031-04-20 | No | 4 | A | Direct |
Footnotes
- Reflects shares purchased from the underwriters in the Companys initial public offering.
- 1/36th of the shares subject to the option vest in equal monthly installments commencing May 21, 2021.